$1.46
-0.04-2.67%
Ult. Agg.: Oct 23, 6:48 PM
Innate Pharma (IPHA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | H1 '26 | H1 '25 | H1 '24 | H1 '23 | FY '25 | FY '24 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||||
| Estimate | $-0.16 | — | — | — | $-0.65 | — |
| Actual | $-0.24 | $-0.28 | $-0.34 | $0.02 | $-0.64 | $-0.65 |
| Surprise | -52.5% | — | — | — | +1.54% | — |
| Revenue | ||||||
| Estimate | $9.1M | — | — | — | $7.2M | — |
| Actual | $6.6M | $5.5M | $13.3M | $43.5M | $10.5M | $21.5M |
| Surprise | -27.7% | — | — | — | +45.0% | — |
| Metric | FY '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-0.59 |
| Revenue | |
| Consensus | $9.4M |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| H1 | Sep 17, 2026 | $-0.24 | $-0.16 | -52.5 % |
| FY | Mar 26, 2026 | $-0.64 | $-0.65 | 1.54 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| H1 | Sep 17, 2026 | $6.58M | $9.10M | -27.7 % |
| FY | Mar 26, 2026 | $10.48M | $7.23M | 45.0 % |